Literature DB >> 5767059

Wilson's disease.

J M Walshe.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1969        PMID： 5767059      PMCID： PMC1187527          DOI： 10.1042/bj1110008p

Source DB:  PubMed          Journal:  Biochem J        ISSN： 0264-6021            Impact factor:   3.857


× No keyword cloud information.
  7 in total

1.  Physicochemical studies of human ceruloplasmin.

Authors:  C B KASPER; H F DEUTSCH
Journal:  J Biol Chem       Date:  1963-07       Impact factor: 5.157

2.  Penicillamine, a new oral therapy for Wilson's disease.

Authors:  J M WALSHE
Journal:  Am J Med       Date:  1956-10       Impact factor: 4.965

3.  THE INCORPORATION OF COPPER INTO CERULOPLASMIN IN VIVO: STUDIES WITH COPPER AND COPPER.

Authors:  I Sternlieb; A G Morell; W D Tucker; M W Greene; I H Scheinberg
Journal:  J Clin Invest       Date:  1961-10       Impact factor: 14.808

4.  Studies on the toxicity of copper. II. The behaviour of microsomal membrane ATPase of the pigeon's brain tissue to copper and some other metallic substances.

Authors:  R Peters; M Shorthouse; J M Walshe
Journal:  Proc R Soc Lond B Biol Sci       Date:  1966-12-13

5.  Studies on the toxicity of copper. I. The toxic action of copper in vivo and in vitro.

Authors:  R Peters; J M Walshe
Journal:  Proc R Soc Lond B Biol Sci       Date:  1966-12-13

6.  Effect of penicillamine on failure of renal acidification in Wilson's disease.

Authors:  J M Walshe
Journal:  Lancet       Date:  1968-04-13       Impact factor: 79.321

7.  The liver-thigh 64Cu ratio in Wilson's disease.

Authors:  A J Levi; H S Williams
Journal:  Clin Sci       Date:  1968-04       Impact factor: 6.124
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.